Materialise NV

Materialise NV

Compare this stock

MTLS Stock Report Card

$

VolatilityTechnicalsProfitPerformanceEarningsAnalyst Price Targets

39%

Performance

Score:

10/100

MTLS returned -46.40% in the last 12 months. Based on SPY's performance of -8.92%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

Score:

75/100

4 analysts offer 12-month price targets for MTLS. Together, they have an average target of 0, the most optimistic target put MTLS at 0 within 12-months and the most pessimistic has MTLS at 0.

Technicals

Score:

36/100

MTLS receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.

Earnings

Score:

10/100

MTLS has missed earnings 6 times in the last 20 quarters.

Profit

Score:

48/100

Out of the last 20 quarters, MTLS has had 11 profitable quarters and has increased their profits year over year on 6 of them.

Volatility

Score:

35/100

MTLS has had a lower than average amount of volatility over the last 12 months giving it a score of 34 of 100.

Materialise NV Summary

Nasdaq / MTLS
Technology
Software - Application
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.